The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.
Open accessAbstract
PD134308 and PD135158 are potent and selective antagonists at the cholecystokinin type B (CCK-B) receptors with IC50 values of 1.6 nM and 3.5 nM, respectively, in the radioligand binding assay and Ke values of 7.82 and 12.9 nM, respectively, in their blocking action on CCK responses in the rat lateral hypothalamic slice. PD134308 and PD135158 produced potent anxiolytic effects in the mouse black/white box test after either subcutaneous or oral administration. There was no evidence of the development of tolerance to the anxiolytic action of either PD134308 or PD135158 in mice treated twice daily for 7 days, nor was there any sign of withdrawal anxiogenesis after abrupt termination of this treatment. Both CCK-B antagonists were able to suppress the withdrawal anxiogenesis and produce an anxiolytic effect in mice previously made tolerant to diazepam. PD134308 and PD135158 produced potent anxiolytic effects in the rat elevated plus maze test and the rat social interaction test. The effects were comparable in magnitude to those seen with diazepam. However, unlike diazepam, PD134308 and PD135158 did not produce sedation. The CCK-B antagonists also showed powerful anxiolytic activity in the "marmoset human threat test." These results provide evidence of a selective role for CCK-B receptors in the control of anxiety. PD134308 and PD135158 are members of a class of anxiolytic agents that have a greatly improved profile compared with benzodiazepines or serotonin-related anxiolytics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O., & SCHILD, H. O. (1959) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1959.tb00928.x · Cited by 3,938
Lee, J. H., Kim, S.-Y., Kwon, Y. K., Kim, B. J., & So, I. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350075 · Cited by 1,380
New peptide in the vertebrate CNS reacting with antigastrin antibodies
VANDERHAEGHEN, J. J., SIGNEAU, J. C., & GEPTS, W. (1975) · Nature · doi:10.1038/257604a0 · Cited by 758
Ho¨kfelt, T., Skirboll, L., Rehfeld, J. F., Goldstein, M., Markey, K., & Dann, O. (1980) · Neuroscience · doi:10.1016/0306-4522(80)90127-x · Cited by 716
Evidence for coexistence of dopamine and CCK in meso-limbic neurones
Hökfelt, T., Rehfeld, J. F., Skirboll, L., Ivemark, B., Goldstein, M., & Markey, K. (1980) · Nature · doi:10.1038/285476a0 · Cited by 707
Immunochemical evidence of cholecystokinin-like peptides in brain
DOCKRAY, G. J. (1976) · Nature · doi:10.1038/264568a0 · Cited by 687
Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia
Faris, P. L., Komisaruk, B. R., Watkins, L. R., & Mayer, D. J. (1983) · Science · doi:10.1126/science.6294831 · Cited by 578
Distinct cholecystokinin receptors in brain and pancreas.
Innis, R. B., & Snyder, S. H. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6917 · Cited by 573
Exploration of mice in a black and white test box: Validation as a model of anxiety
Costall, B., Jones, B. J., Kelly, M. E., Naylor, R. J., & Tomkins, D. M. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90033-6 · Cited by 544
Self-citationChang, R. S., & Lotti, V. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4923 · Cited by 540
Cited by
Bourin, M., & Hascoët, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01274-3 · Cited by 1,427
Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical Perspectives
Giannis, A., & Kolter, T. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199312441 · Cited by 784
Biological actions of cholecystokinin
Crawley, J. N., & Corwin, R. L. (1994) · Peptides · doi:10.1016/0196-9781(94)90104-x · Cited by 712
Neuropeptides in perspective: The last ten years
Hökfelt, T. (1991) · Neuron · doi:10.1016/0896-6273(91)90333-u · Cited by 618
Hökfelt, T., Broberger, C., Xu, Z.-Q. D., Sergeyev, V., Ubink, R., & Diez, M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00010-1 · Cited by 604
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Crawley, J. N., & Paylor, R. (1997) · Hormones and Behavior · doi:10.1006/hbeh.1997.1382 · Cited by 553
Cholecystokinin and Gastrin Receptors
Dufresne, M., Seva, C., & Fourmy, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00014.2005 · Cited by 476
Wank, S. A., Harkins, R., Jensen, R. T., Shapira, H., de Weerth, A., & Slattery, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3125 · Cited by 403
Noble, F., Wank, S. A., Crawley, J. N., Bradwejn, J., Seroogy, K. B., Hamon, M., & Roques, B. P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01427-3 · Cited by 384
Heimer, L., Harlan, R. E., Alheid, G. F., Garcia, M. M., & de Olmos, J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00405-8 · Cited by 288
Behavioral effects of neuropeptides in rodent models of depression and anxiety
Rotzinger, S., Lovejoy, D. A., & Tan, L. A. (2010) · Peptides · doi:10.1016/j.peptides.2009.12.015 · Cited by 211
Cortical sources of CRF, NKB, and CCK and their effects on pyramidal cells in the neocortex
Gallopin, T., Geoffroy, H., Rossier, J., & Lambolez, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj081 · Cited by 97
Arey, R. N., Enwright, J. F., Spencer, S. M., Falcon, E., Ozburn, A. R., Ghose, S., Tamminga, C., & McClung, C. A. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.12 · Cited by 62
CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies
Harro, J. (2006) · Amino Acids · doi:10.1007/s00726-006-0334-x · Cited by 64
Kobayashi, S., Ohta, M., Miyasaka, K., & Funakoshi, A. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12881-0 · Cited by 44
“It has been reported [13,14,16,18] that the CCK-B receptor is involved in anxiety, and the CCK-A receptor has been implicated in satiety and behavior.”
BackgroundHascoët, M., & Bourin, M. (2009) · Neuromethods · doi:10.1007/978-1-60761-303-9_11 · Cited by 26
Metadata
- Authors
- Hughes, J., Boden, P., Costall, B., Domeney, A., Kelly, E., Horwell, D. C., Hunter, J. C., Pinnock, R. D., & Woodruff, G. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1990-09
- Volume
- 87
- Issue
- 17
- Pages
- 6728-6732
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2027119507
- Cited by
- 501
- References
- 25
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.